cerrar
Tagged with USA

US-China Tensions Heating Up in the Life Sciences
Eurasia Group’s Aditya Bhattacharji looks at the potentially damaging fallout of the ongoing US-China trade war on the life sciences industry.…

Peter Dahlen – Managing Director, American Chamber of…
The American Chamber of Commerce in Sweden promotes trade and investment between the USA and Sweden. Peter Dahlen, AmCham Sweden’s managing…

Shun Luo – Chairman, Founder and CEO, Thousand Oaks…
Dr Shun Luo, chairman, founder and CEO of Thousand Oaks Biopharmaceuticals, shares the company’s vision to deliver more accessible and affordable…

Top 20 Drugs in the USA 2018
The bestselling drugs of 2018 in the USD 485 billion US pharma market. The list features several major blockbusters benefiting from the delays in…

Christopher P. Molineaux – President & CEO, Life…
Christopher P. Molineaux of Life Sciences Pennsylvania outlines the Keystone State’s rich lineage of pharmaceutical innovation, how the association…

An International Approach to Boosting the US Biosimilars Market
Chip Davis of the Association for Accessible Medicines argues that learning from the European biosimilars approval experience could speed up patient…

Tales from the Trenches: One Female Pharma Executive’s…
US industry veteran Sharon Ayd describes her journey to becoming a pharma company board member, the various hurdles still facing female pharma…

Patents: A Key Factor in Winning the Cannabis Arms Race
A new white paper from Fasken law firm asserts that the early filing of patents for innovative products is crucial for companies hoping to succeed in…

The “CDP” Cure for Common “Rx” Marketing
Meghann Chilcott offers an introductory look at the potential of customer data platforms (CDPs) to transform the way pharmacy marketers reach out to…

Value Based Care: In Need of More Patient and Physician Voices
Carla Smith outlines the role that a value-based care (VBC) approach can have on both reducing healthcare costs and improving overall care delivery to…

Let’s Treat Cannabis Like the Medicine It’s Been For Over…
David Bearman makes the historical case to be once again considered as a medicine across the USA, noting that economic – rather than health –…

The US Generic Drug Supply Chain: “Standardized,…
Chip Davis is head of the Association for Accessible Medicines (AAM) which advocates for greater uptake of generic and biosimilar drugs in the USA.…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here